Market Cap : 16.49 B | Enterprise Value : 13.81 B | PE Ratio : 17.44 | PB Ratio : 4.03 |
---|
NAS:INCY has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:INCY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Incyte has an F-score of 5 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for Incyte's Piotroski F-Score or its related term are showing as below:
During the past 13 years, the highest Piotroski F-Score of Incyte was 8. The lowest was 1. And the median was 4.
The historical data trend for Incyte's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Incyte's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Incyte's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Incyte's Piotroski F-Score falls into.
How is the Piotroski F-Score calculated?
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This Year (Jun22) TTM: | Last Year (Jun21) TTM: |
Net Income was 181.739 + 563.851 + 37.992 + 161.432 = $945 Mil. Cash Flow from Operations was 255.098 + 115.351 + 215.741 + 174.157 = $760 Mil. Revenue was 812.987 + 862.853 + 733.235 + 911.397 = $3,320 Mil. Gross Profit was 773.087 + 818.953 + 690.635 + 860.797 = $3,143 Mil. Average Total Assets from the begining of this year (Jun21) to the end of this year (Jun22) was (3904.623 + 4198.831 + 4933.352 + 5054.221 + 5319.035) / 5 = $4682.0124 Mil. Total Assets at the begining of this year (Jun21) was $3,905 Mil. Long-Term Debt & Capital Lease Obligation was $31 Mil. Total Current Assets was $3,626 Mil. Total Current Liabilities was $927 Mil. |
Net Income was -15.203 + 149.85 + 53.535 + 149.456 = $338 Mil. Revenue was 620.643 + 789.509 + 604.718 + 705.709 = $2,721 Mil. Gross Profit was 586.343 + 753.209 + 575.518 + 667.709 = $2,583 Mil. Average Total Assets from the begining of last year (Jun20) to the end of last year (Jun21) was (3212.321 + 3307.43 + 3560.918 + 3661.436 + 3904.623) / 5 = $3529.3456 Mil. Total Assets at the begining of last year (Jun20) was $3,212 Mil. Long-Term Debt & Capital Lease Obligation was $32 Mil. Total Current Assets was $2,620 Mil. Total Current Liabilities was $660 Mil. |
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Incyte's current Net Income (TTM) was 945.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Incyte's current Cash Flow from Operations (TTM) was 760.
==> Positive ==> Score 1.
Question 3. Change in Return on Assets
Compare this year's return on assets (1) to last year's return on assets.
Score 1 if it's higher, 0 if it's lower.
ROA (This Year) | = | Net Income | / | Total Assets (Jun21) |
= | 945.014 | / | 3904.623 | |
= | 0.24202439 |
ROA (Last Year) | = | Net Income | / | Total Assets (Jun20) |
= | 337.638 | / | 3212.321 | |
= | 0.10510718 |
Incyte's return on assets of this year was 0.24202439. Incyte's return on assets of last year was 0.10510718.
==> This year is higher. ==> Score 1.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Score 1 if CFROA > ROA, 0 if CFROA <= ROA.
Incyte's current Net Income (TTM) was 945. Incyte's current Cash Flow from Operations (TTM) was 760.
==> 760 <= 945 ==> CFROA <= ROA ==> Score 0.
Funding
Question 5. Change in Gearing or Leverage
Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.
Score 0 if this year's gearing is higher, 1 otherwise.
Gearing (This Year: Jun22) | = | Long-Term Debt & Capital Lease Obligation | / | Average Total Assets from Jun21 to Jun22 |
= | 31.157 | / | 4682.0124 | |
= | 0.00665462 |
Gearing (Last Year: Jun21) | = | Long-Term Debt & Capital Lease Obligation | / | Average Total Assets from Jun20 to Jun21 |
= | 31.838 | / | 3529.3456 | |
= | 0.00902094 |
Incyte's gearing of this year was 0.00665462. Incyte's gearing of last year was 0.00902094.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Current Ratio (This Year: Jun22) | = | Total Current Assets | / | Total Current Liabilities |
= | 3625.845 | / | 926.674 | |
= | 3.91275141 |
Current Ratio (Last Year: Jun21) | = | Total Current Assets | / | Total Current Liabilities |
= | 2620.06 | / | 660.324 | |
= | 3.96784003 |
Incyte's current ratio of this year was 3.91275141. Incyte's current ratio of last year was 3.96784003.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Incyte's number of shares in issue this year was 223.661. Incyte's number of shares in issue last year was 222.25.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Gross Margin (This Year: TTM) | = | Gross Profit | / | Revenue |
= | 3143.472 | / | 3320.472 | |
= | 0.94669433 |
Gross Margin (Last Year: TTM) | = | Gross Profit | / | Revenue |
= | 2582.779 | / | 2720.579 | |
= | 0.94934902 |
Incyte's gross margin of this year was 0.94669433. Incyte's gross margin of last year was 0.94934902.
==> Last year's gross margin is higher ==> Score 0.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Asset Turnover (This Year) | = | Revenue | / | Total Assets at the Beginning of This Year (Jun21) |
= | 3320.472 | / | 3904.623 | |
= | 0.85039503 |
Asset Turnover (Last Year) | = | Revenue | / | Total Assets at the Beginning of Last Year (Jun20) |
= | 2720.579 | / | 3212.321 | |
= | 0.84692003 |
Incyte's asset turnover of this year was 0.85039503. Incyte's asset turnover of last year was 0.84692003.
==> This year's asset turnover is higher. ==> Score 1.
Evaluation
Piotroski F-Score | = | Que. 1 | + | Que. 2 | + | Que. 3 | + | Que. 4 | + | Que. 5 | + | Que. 6 | + | Que. 7 | + | Que. 8 | + | Que. 9 |
= | 1 | + | 1 | + | 1 | + | 0 | + | 1 | + | 0 | + | 0 | + | 0 | + | 1 | |
= | 5 |
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Incyte has an F-score of 5 indicating the company's financial situation is typical for a stable company.
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Thank you for viewing the detailed overview of Incyte's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.
Tray Thomas | officer: Principal Accounting Officer | C/O INCYTE CORPORATION 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 |
Brawley Otis W | director | 5203 BRISTOL INDUSTRIAL WAY BUFORD GA 30518 |
High Katherine A | director | 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 |
Harrigan Edmund | director | |
Morrissey Michael James | officer: EVP, Head of Tech. Operations | IN CARE OF INCYTE CORPORATION 1801 AUGUSTINE CUT OFF WILMINGTON DE 19803 |
Dickinson Jonathan Elliott | officer: EVP, General Manager, Europe | CARE OF INCYTE CORPORATION 1801 AUGUSTINE CUT OFF WILMINGTON DE 19803 |
Stamoulis Christiana | officer: EVP & Chief Financial Officer | C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST CAMBRIDGE MA 02139 |
Dhanak Dashyant | officer: EVP & Chief Scientific Officer | C/O INCYTE CORPORATION 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 |
Pasquale Maria E | officer: EVP & General Counsel | C/O INCYTE CORPORATION 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 |
Fouse Jacqualyn A | director | C/O DICK'S SPORTING GOODS 345 COURT STREET CORAOPOLIS PA 15108 |
Iyengar Vijay K | officer: EVP GPS, BD, & Licensing | 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 |
Stein Steven H | officer: EVP & Chief Medical Officer | 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 |
Trower Paul | officer: VP, Finance & Prin Acc Officer | 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 |
Clancy Paul J | director | C/O BIOGEN IDEC INC. 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142 |
Bienaime Jean Jacques | director | 925 PAGE MILL ROAD PALO ALTO CA 94304 |
From GuruFocus
Other Sources
By Zacks 2022-02-03
By tipranks.com 2022-02-11
By Seekingalpha 2022-01-24
By Zacks 2021-12-16
By Zacks 2022-01-31
By tipranks.com 2022-02-10
By Zacks 2021-12-06
By tipranks.com 2022-02-09
By Zacks 2022-03-10
By tipranks.com 2022-03-14
By Zacks 2022-02-09
By Zacks 2022-02-08
By Zacks 2021-12-02
By tipranks.com 2022-02-08